Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell Function

Area of Science:

• Biotechnology
• Immunology
• Cell Biology

Background:

• Developing reliable quality control tools is essential for advancing cell and antibody therapies.
• Existing methods may lack the specificity required for complex biological systems.

Purpose of the Study:

• To create genetically engineered isogenic cell lines for validating novel therapeutic and diagnostic tools.
• To establish a versatile platform for assessing the specificity and function of engineered biological agents.

Main Methods:

• Generation of isogenic cell lines expressing specific antigens (folate receptor alpha, mesothelin) and reporter genes.
• Utilizing these cell lines to authenticate the specificity and function of T-cell biofactories and chimeric antigen receptor T cells.
• Assessing the specificity of monoclonal antibodies using the engineered cell lines.

Main Results:

• Successfully developed cell lines expressing target antigens and reporter genes.
• Validated the specificity and function of a T-cell biofactory.
• Confirmed the specificity of chimeric antigen receptor T cells and monoclonal antibodies.
• Demonstrated the utility of these cell lines as versatile quality control tools.

Conclusions:

• The developed engineered cell lines provide a robust platform for quality control in immunotherapy and diagnostics.
• This strategy enables the creation of custom cell lines for various disease biomarkers.
• These tools are critical for ensuring the safety and efficacy of novel cell-based and antibody-based therapies.